China Pipe (00380) announces annual performance, with a net profit attributable to shareholders of HK$55.96 million, a 36% decrease year-on-year.
China Pipe Group (00380) announced its annual performance for the year ending on December 31, 2025. The group achieved revenue of HK$645 million, a decrease of 18% year-on-year; the net profit attributable to equity holders of the company was HK$55.966 million, a decrease of 36% year-on-year; basic earnings per share was 4.2 HK cents.
China Pipe (00380) announced its annual performance for the year ending December 31, 2025. The group achieved a revenue of HK$645 million, a decrease of 18% compared to the previous year. The net profit attributable to equity holders of the company was HK$55.966 million, a decrease of 36% compared to the previous year. The basic earnings per share were 4.2 HK cents.
The announcement stated that the revenue for the year showed a downward trend, mainly due to the completion of several large-scale infrastructure projects' pipeline and pipe fitting supply contracts, which were key pillars of the outstanding performance in 2024. In addition, the continued slowdown in the private construction industry in 2025 also suppressed the demand for pipelines and pipe fittings.
Related Articles

YESASIA HLDGS (02209) announced its annual performance, with a net profit attributable to shareholders of 23.15 million US dollars, an increase of 21.83% year-on-year.

MAIYUE TECH (02501) appoints Guan Xiongjun as company secretary.

BAOYE GROUP (02355) announces annual performance, with a net profit attributable to shareholders of 290 million yuan, a 29.34% decrease year-on-year.
YESASIA HLDGS (02209) announced its annual performance, with a net profit attributable to shareholders of 23.15 million US dollars, an increase of 21.83% year-on-year.

MAIYUE TECH (02501) appoints Guan Xiongjun as company secretary.

BAOYE GROUP (02355) announces annual performance, with a net profit attributable to shareholders of 290 million yuan, a 29.34% decrease year-on-year.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


